BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15260947)

  • 1. The genes for schizophrenia: finally a breakthrough?
    Shirts BH; Nimgaonkar V
    Curr Psychiatry Rep; 2004 Aug; 6(4):303-12. PubMed ID: 15260947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample.
    Réthelyi JM; Bakker SC; Polgár P; Czobor P; Strengman E; Pásztor PI; Kahn RS; Bitter I
    Am J Med Genet B Neuropsychiatr Genet; 2010 Apr; 153B(3):792-801. PubMed ID: 19937977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linkage and association studies of schizophrenia.
    McGuffin P; Tandon K; Corsico A
    Curr Psychiatry Rep; 2003 Jun; 5(2):121-7. PubMed ID: 12685991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In search of susceptibility genes for schizophrenia].
    Schosser A; Aschauer HN
    Wien Klin Wochenschr; 2004 Dec; 116(24):827-33. PubMed ID: 15690966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology.
    Craddock N; O'Donovan MC; Owen MJ
    Schizophr Bull; 2006 Jan; 32(1):9-16. PubMed ID: 16319375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of recently detected susceptibility genes for schizophrenia.
    Maier W; Zobel A; Kühn KU
    Dialogues Clin Neurosci; 2006; 8(1):79-84. PubMed ID: 16640117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of COMT, BDNF, 5-HTT, NRG1 and DTNBP1 genes on hippocampal and lateral ventricular volume in psychosis.
    Dutt A; McDonald C; Dempster E; Prata D; Shaikh M; Williams I; Schulze K; Marshall N; Walshe M; Allin M; Collier D; Murray R; Bramon E
    Psychol Med; 2009 Nov; 39(11):1783-97. PubMed ID: 19573260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizophrenia: genes at last?
    Owen MJ; Craddock N; O'Donovan MC
    Trends Genet; 2005 Sep; 21(9):518-25. PubMed ID: 16009449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common risk genes for affective and schizophrenic psychoses.
    Maier W
    Eur Arch Psychiatry Clin Neurosci; 2008 Jun; 258 Suppl 2():37-40. PubMed ID: 18516516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia.
    Bakker SC; Hoogendoorn ML; Hendriks J; Verzijlbergen K; Caron S; Verduijn W; Selten JP; Pearson PL; Kahn RS; Sinke RJ
    Genes Brain Behav; 2007 Mar; 6(2):113-9. PubMed ID: 17410640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene polymorphism and gene expression in schizophrenia].
    Mátyás T
    Psychiatr Hung; 2006; 21(6):404-12. PubMed ID: 17438657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on the genetics of schizophrenia.
    Norton N; Williams HJ; Owen MJ
    Curr Opin Psychiatry; 2006 Mar; 19(2):158-64. PubMed ID: 16612196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic meta-analysis of the association of Neuregulin 1 (NRG1), D-amino acid oxidase (DAO), and DAO activator (DAOA)/G72 polymorphisms with schizophrenia.
    Jagannath V; Gerstenberg M; Correll CU; Walitza S; Grünblatt E
    J Neural Transm (Vienna); 2018 Jan; 125(1):89-102. PubMed ID: 28864885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the genetics of schizophrenia.
    O'Donovan MC; Williams NM; Owen MJ
    Hum Mol Genet; 2003 Oct; 12 Spec No 2():R125-33. PubMed ID: 12952866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of schizophrenia and bipolar disorder candidate genes using chromatin immunoprecipitation and tiled microarrays (ChIP-chip).
    Pedrosa E; Locker J; Lachman HM
    J Neurogenet; 2009; 23(3):341-52. PubMed ID: 19225952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia.
    Nicodemus KK; Kolachana BS; Vakkalanka R; Straub RE; Giegling I; Egan MF; Rujescu D; Weinberger DR
    Hum Genet; 2007 Feb; 120(6):889-906. PubMed ID: 17006672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cis- and trans- loci influence expression of the schizophrenia susceptibility gene DTNBP1.
    Bray NJ; Holmans PA; van den Bree MB; Jones L; Elliston LA; Hughes G; Richards AL; Williams NM; Craddock N; Owen MJ; O'Donovan MC
    Hum Mol Genet; 2008 Apr; 17(8):1169-74. PubMed ID: 18182443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland.
    Turunen JA; Peltonen JO; Pietiläinen OP; Hennah W; Loukola A; Paunio T; Silander K; Ekelund J; Varilo T; Partonen T; Lönnqvist J; Peltonen L
    Schizophr Res; 2007 Mar; 91(1-3):27-36. PubMed ID: 17300918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An exploratory association study of the influence of dysbindin and neuregulin polymorphisms on brain morphometry in patients with schizophrenia and healthy subjects from South India.
    Thirunavukkarasu P; Vijayakumari AA; John JP; Halahalli HN; Paul P; Sen S; Purushottam M; Jain S
    Asian J Psychiatr; 2014 Aug; 10():62-8. PubMed ID: 25042954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia.
    Numakawa T; Yagasaki Y; Ishimoto T; Okada T; Suzuki T; Iwata N; Ozaki N; Taguchi T; Tatsumi M; Kamijima K; Straub RE; Weinberger DR; Kunugi H; Hashimoto R
    Hum Mol Genet; 2004 Nov; 13(21):2699-708. PubMed ID: 15345706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.